Edition:
United Kingdom

People: Poxel SA (POXEL.PA)

POXEL.PA on Paris Stock Exchange

6.34EUR
26 Jun 2019
Change (% chg)

-- (--)
Prev Close
€6.34
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
138,998
52-wk High
€9.18
52-wk Low
€4.92

Boissel, Pascale 

Ms. Pascale Boissel has been Independent Director of Poxel SA since March 5, 2015. She is Chairman of company's Audit Committee and Member of Governance and Nominating Committee. She is a consultant in finance and restructuring operations, a field in which she has 25 years of experience. She is the part-time CFO of Novadiscovery, a biotech company which develops models and simulations in order to avoid the risks in developing new drugs. Before that, she was previously the Deputy-Chief Executive Officer and Head of Finance and Administration of the BIOASTER institute, a French not-for-profit organization that develops collaborative research programs in the field of infectious diseases and microbiology. In 2009, Madame Boissel joined biotech company Ipsogen in the United States and was responsible for financing activities. She played a major role in the transaction which led to completion of the acquisition of Ipsogen in 2011. Before joining Ipsogen, she worked for listed French companies, as Deputy Chief Financial Officer, in the sector of transactions and commercial control. Pascale Boissel began her career in audit and corporate finance at PricewaterhouseCoopers. She has significant experience in international accounting practices. She holds MBA from HEC and is Certified Accountant.

Basic Compensation

Total Annual Compensation, EUR --
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 109,693
Fiscal Year Total, EUR 109,693

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --